Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹163 Cr₹170 Cr₹84 Cr₹88 Cr₹74 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA is ₹163 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹163 Cr
Mar2024₹170 Cr
Mar2023₹84 Cr
Mar2022₹88 Cr
Mar2021₹74 Cr

How is Deferred Tax Assets / Liabilities of GLAND PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹163 Cr
-4.09
Mar2024 ₹170 Cr
101.52
Mar2023 ₹84 Cr
-4.05
Mar2022 ₹88 Cr
18.79
Mar2021 ₹74 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹40,058.7 Cr -2.3% 4.9% 18.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹473,509.0 Cr 0.6% 6% 14.6% Stock Analytics
DIVIS LABORATORIES ₹196,881.0 Cr 1.2% 10.5% 7.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,832.0 Cr -0.4% 11% 40.8% Stock Analytics
CIPLA ₹113,894.0 Cr -1.6% -2.1% -4.8% Stock Analytics
DR REDDYS LABORATORIES ₹96,062.8 Cr -4.6% -14.8% -8.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.3%

4.9%

18.9%

SENSEX

-1.1%

-0.2%

-6.6%


You may also like the below Video Courses